Eton Pharmaceuticals, Inc. · NASDAQ:ETON
Brynjelsen Sean exercised options for 227,500 Eton Pharmaceuticals, Inc. shares (Form 4)
Traded Jul 12 to Jul 14, 2026 · Filed Jul 14, 2026
From Jul 12 to Jul 14, 2026, Brynjelsen Sean (Director, President & CEO) exercised options for 227,500 Eton Pharmaceuticals, Inc. shares at US$1.37 for US$274K, leaving 1,061,194 shares. Filed Jul 14, 2026 (Form 4).
- Options exercised
- 227,500 shares
- Price
- US$1.37
- Value
- US$274K
- Holding after
- 1,061,194 shares
- Trading plan
- No
- Role
- Director, President & CEO
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jul 12, 2026 | Common Stock | Option exercise | 27,500 | 861,194 | Direct | |
| Jul 14, 2026 | Common Stock | Option exercise | 200,000 | US$1.37 | 1,061,194 | Direct |
Source
Related
- Eton Pharmaceuticals, Inc.
- Brynjelsen Sean
- Eton Pharmaceuticals, Inc. shareholders
- Form 4 · Brynjelsen Sean · Aug 20, 2026
- Form 4 · Brynjelsen Sean · May 29, 2026
- Form 4 · Krempa David · Oct 6, 2026
- Form 4/A · Maier Paul V · Aug 31, 2026
- Form 4 · Krempa David · Aug 24, 2026
- Schedule 13G/A · BlackRock, Inc. · Jul 28, 2026
- Form 4/A · Opaleye Management Inc. · Jul 17, 2026